Meet
Features
Solutions
Pricing
Sales Intelligence
Qualify prospects and connect with decision makers effortlessly
Research Companies & Directors
Make important decisions with absolute confidence
Create B2B Marketing Lists
Target and reach more of your ideal prospects than ever
Monitor Risks & Opportunities
Be the first to learn about changes in the companies that matter
Cleanse Your B2B Database
Instantly transform old records into new opportunities
Perform KYC Checks
Completely understand who you're working with
Discover New Businesses
Identify and connect with new companies as soon as they register
Company Credit Reports
See how companies are performing year–on–year and explore their debts
UPGRADE
Contact
Credit Report
Financials
People
Ownership
Latest Activity
Mutual Companies
Documents
Repayment History
Disruptyx Therapeutics Limited
Disruptyx Therapeutics Limited is a dormant company incorporated on 6 May 2022 with the registered office located in Glasgow, City of Glasgow. Disruptyx Therapeutics Limited was registered 3 years ago.
Watch Company
Status
Dormant
Dormant since
incorporation
Company No
SC731650
Private limited company
Scottish Company
Age
3 years
Incorporated
6 May 2022
Size
Micro
Turnover is under
£1M
Balance sheet is under
£500,000
Under
10 employees
Confirmation
Submitted
Dated
5 May 2025
(4 months ago)
Next confirmation dated
5 May 2026
Due by
19 May 2026
(8 months remaining)
Last change occurred
3 months ago
Accounts
Submitted
For period
1 Jun
⟶
31 May 2024
(1 year)
Accounts type is
Dormant
Next accounts for period
31 May 2025
Due by
28 February 2026
(5 months remaining)
Learn more about Disruptyx Therapeutics Limited
Contact
Address
11 The Square
University Avenue
Glasgow
G12 8QQ
United Kingdom
Same address since
incorporation
Companies in G12 8QQ
Telephone
Unreported
Email
Unreported
Website
Disruptyxtherapeutics.com
See All Contacts
People
Officers
2
Shareholders
4
Controllers (PSC)
2
Dr Connor Macleod Blair
Director • Biotechnology • British • Lives in Scotland • Born in May 1993
Dr Douglas Fraser Gray
Director • British • Lives in England • Born in Oct 1965
Professor George Scott Baillie
PSC • British • Lives in Scotland • Born in Dec 1966
Dr Connor Macleod Blair
PSC • British • Lives in Scotland • Born in May 1993
See Key People
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
See All Shareholders, PSCs & Group Structure
Mutual Companies
Gray Pharma Consulting Limited
Dr Douglas Fraser Gray is a mutual person.
Active
Hornet Therapeutics Ltd
Dr Douglas Fraser Gray is a mutual person.
Active
See All Mutual Companies
Financials
Net Assets, Total Assets & Total Liabilities (2023–2024)
Period Ended
31 May 2024
For period
31 May
⟶
31 May 2024
Traded for
12 months
Cash in Bank
£150
Same as previous period
Turnover
Unreported
Same as previous period
Employees
Unreported
Same as previous period
Total Assets
£150
Same as previous period
Total Liabilities
£0
Same as previous period
Net Assets
£150
Same as previous period
Debt Ratio (%)
0%
Same as previous period
See 10 Year Full Financials
Latest Activity
Confirmation Submitted
3 Months Ago on 30 May 2025
Dr. Connor Macleod Blair Appointed
5 Months Ago on 28 Mar 2025
Dr Connor William Blair (PSC) Details Changed
5 Months Ago on 28 Mar 2025
Douglas Fraser Gray (PSC) Resigned
6 Months Ago on 14 Mar 2025
Douglas Fraser Gray Resigned
6 Months Ago on 14 Mar 2025
Dormant Accounts Submitted
1 Year 3 Months Ago on 7 Jun 2024
Confirmation Submitted
1 Year 3 Months Ago on 7 Jun 2024
Dormant Accounts Submitted
1 Year 10 Months Ago on 27 Oct 2023
Confirmation Submitted
2 Years 2 Months Ago on 21 Jun 2023
George Scott Baillie (PSC) Appointed
3 Years Ago on 12 Sep 2022
Get Alerts
Get Credit Report
Discover Disruptyx Therapeutics Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
See All Credit Score & Limits
Documents
Confirmation statement made on 5 May 2025 with updates
Submitted on 30 May 2025
Appointment of Dr. Connor Macleod Blair as a director on 28 March 2025
Submitted on 28 Mar 2025
Cessation of Douglas Fraser Gray as a person with significant control on 14 March 2025
Submitted on 28 Mar 2025
Change of details for Dr Connor William Blair as a person with significant control on 28 March 2025
Submitted on 28 Mar 2025
Termination of appointment of Douglas Fraser Gray as a director on 14 March 2025
Submitted on 14 Mar 2025
Confirmation statement made on 5 May 2024 with no updates
Submitted on 7 Jun 2024
Accounts for a dormant company made up to 31 May 2024
Submitted on 7 Jun 2024
Accounts for a dormant company made up to 31 May 2023
Submitted on 27 Oct 2023
Confirmation statement made on 5 May 2023 with updates
Submitted on 21 Jun 2023
Notification of Connor William Blair as a person with significant control on 12 September 2022
Submitted on 20 Sep 2022
Explore All Documents
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year
See All Charges & CCJs